The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus

2020 ◽  
Vol 14 (5) ◽  
pp. 482-487 ◽  
Author(s):  
Türkan Akyol Güner ◽  
Gülhan Coşansu
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Disease Management ◽  
Metabolic Control ◽  
Short Message Service ◽  
Diabetes Education ◽  
Short Message ◽  
Message Service

scholarly journals Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus

2014 ◽  
Vol 58 (4) ◽  
pp. 369-376 ◽  
Author(s):  
Joelma Ines Tagliapietra Barros ◽  
Francisco Vagnaldo Fechine ◽  
Renan Magalhães Montenegro Júnior ◽  
Otoni Cardoso do Vale ◽  
Virgínia Oliveira Fernandes ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Evoked Potentials ◽  
Metabolic Control ◽  
Somatosensory Evoked Potentials ◽  
Before And After ◽  
Effect Of Treatment ◽  
Established Role

Objective: To evaluate the effect of sitagliptin on somatosensory-evoked potentials (SEPs) and metabolic control in patients with type 2 diabetes mellitus without clinical diabetic neuropathy. Materials and methods: Interventional, prospective, and open study. Patients with less than six months from the diagnosis were included. Examinations of SEPs and laboratory tests at fasting and after food stimulation were performed before and after three months of treatment with sitagliptin (100 mg/day). Results: There was a reduction in the mean levels of HbA1c (P < 0.0001), fasting glucose (P = 0.001), total cholesterol (P = 0.019), and ALT (P = 0.022). An increase in active GLP-1 was found at the end of the study (P = 0.0025). Several SEPs showed statistically significant differences when analyzed before and after treatment with sitagliptin. Conclusion: The results give a glimpse of the possible use of sitagliptin in the treatment of some neurodegenerative conditions of the peripheral nervous system, in addition to its already established role in glycemic control.

Antipsychotic Drugs May Worsen Metabolic Control in Type 2 Diabetes Mellitus

2004 ◽  
Vol 65 (5) ◽  
pp. 674-678 ◽  
Author(s):  
José A. Spoelstra ◽  
Ronald P. Stolk ◽  
Dan Cohen ◽  
Olav H. Klungel ◽  
Joëlle A. Erkens ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
Antipsychotic Drugs

scholarly journals Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages

2020 ◽  
Vol 34 (11) ◽  
pp. 107708
Author(s):  
M.A. Valtierra-Alvarado ◽  
J.E. Castañeda Delgado ◽  
S.I. Ramírez-Talavera ◽  
G. Lugo-Villarino ◽  
F. Dueñas-Arteaga ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
Human Monocytes
Sign in / Sign up

Export Citation Format

Share Document